ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

NDRA ENDRA Life Sciences Inc

0.3079
0.0204 (7.10%)
Pre Market
Last Updated: 07:07:41
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
ENDRA Life Sciences Inc NDRA NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.0204 7.10% 0.3079 07:07:41
Open Price Low Price High Price Close Price Previous Close
0.2875
more quote information »

Recent News

Date Time Source Heading
5/02/202407:00BWENDRA Life Sciences Strengthens Intellectual Property with..
3/28/202415:05BWENDRA Life Sciences Reports Fourth Quarter and Full Year..
3/21/202407:00BWENDRA Life Sciences to Report Fourth Quarter 2023 Financial..
2/27/202407:00BWENDRA Life Sciences Installs First TAEUS System in the UK
2/23/202416:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/21/202407:00BWNew ICD-10-CM Code by the World Health Organization Paves..
2/14/202407:30BWENDRA Life Sciences Bolsters TAEUS® System Intellectual..
12/29/202316:07EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
11/29/202307:00BWENDRA Life Sciences Secures 39th U.S. Patent for TAEUS®..
11/27/202307:00BWENDRA Life Sciences to Participate in The Benchmark..
11/14/202315:05BWENDRA Life Sciences Reports Third Quarter 2023 Financial..
11/14/202315:02EDGAR2Form 8-K - Current report
11/08/202307:00BWENDRA Life Sciences Achieves Intellectual Property Milestone..
11/07/202315:05BWENDRA Life Sciences to Report Third Quarter 2023 Financial..
11/06/202307:00BWENDRA to Host Multidisciplinary Clinical Discussion on..
9/07/202307:00BWAbstract for ENDRA Life Sciences' TAEUS System Accepted for..
8/30/202307:00BWENDRA Life Sciences' TAEUS De Novo Submission Advances to..
8/23/202307:00BWENDRA Life Sciences Expands Intellectual Property with..
8/14/202315:45EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/14/202315:13EDGAR2Form 8-K - Current report
8/14/202315:05BWENDRA Life Sciences Reports Second Quarter 2023 Financial..
8/14/202312:30BWENDRA Life Sciences Submits De Novo Request for its TAEUS®..
8/10/202307:01EDGAR2Form 8-K - Current report
8/01/202307:00BWENDRA Life Sciences to Report Second Quarter 2023 Financial..
7/25/202315:02EDGAR2Form 8-K - Current report
7/06/202316:25EDGAR2Form 8-K - Current report
7/06/202316:25EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
7/06/202315:45BWENDRA Life Sciences Announces Adjournment of 2023 Annual..
6/07/202307:00BWStudy Highlighting ENDRA Life Sciences’ TAEUS Technology to..
5/15/202315:05BWENDRA Life Sciences Reports First Quarter 2023 Financial..
5/04/202307:00BWENDRA Life Sciences to Report First Quarter 2023 Financial..

Your Recent History

Delayed Upgrade Clock